Back to Research

Organization profile

Science Corporation

Science Corporation is a vertically integrated neural engineering company that develops brain-computer interfaces and medical devices designed to restore and extend life. Its lead product, the PRIMA retinal implant, restores sight to patients with advanced macular degeneration, while its Ecosystem platform provides the foundational technology for the next generation of neural therapies.

Kreuzlingen, SwitzerlandFounded 2021

Overview

1. Executive Summary (Confidence: High)

Science Corporation is a clinical-stage medtech leader focused on solving the most profound challenges in neural engineering.[6] Founded in 2021 by Max Hodak, the organization operates as a "full-stack" company, developing both proprietary patient-facing therapies and the vertically integrated infrastructure (Science Foundry/Ecosystem) that the broader neurotech industry relies on.[2]

In early 2026, Science announced a massive $230 million Series C financing round, bringing its total capital to $490 million, designated for the commercialization of its PRIMA retinal implant.[7] Clinical results published in the New England Journal of Medicine (NEJM) confirmed that 80% of blind participants using PRIMA regained the ability to read letters and words.[7] With regulatory applications pending in both the EU and US, Science is poised to become the first BCI company to achieve a commercial-scale launch of a vision restoration device.[9]

This is an extract of the full organization profile. To access the full company profile, .

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.